Good User Reputation for Irinotecan - Lurasidone Hydrochloride CAS 367514-88-3 API High Purity – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

We will devote ourselves to providing our esteemed customers with the most enthusiastically thoughtful services for Molecular Weight 206.33, C7H2ClF3O2, p-Aminobenzamide glutamic acid, Create Values,Serving Customer!" is the aim we pursue. We sincerely hope that all customers will establish long term and mutually beneficial cooperation with us.If you wish to get more details about our company, Please contact with us now.
Good User Reputation for Irinotecan - Lurasidone Hydrochloride CAS 367514-88-3 API High Purity – Ruifu Detail:

Manufacturer Supply with High Purity and Stable Quality
Lurasidone Hydrochloride (CAS 367514-88-3) Related Intermediates:
(1R,2R)-1,2-Cyclohexanedimethanol CAS 65376-05-8
(3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione CAS 14805-29-9
Lurasidone Hydrochloride CAS 367514-88-3 API
High Quality, Commercial Production

Chemical Name Lurasidone Hydrochloride
Synonyms Lurasidone HCl; Latuda
CAS Number 367514-88-3
CAT Number RF-API64
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C28H36N4O2S
Molecular Weight 492.684
Melting Point 198.0~205.0°C
Shipping Condition Shipped Under Ambient Temperature
Brand Ruifu Chemical
Item Specifications
Appearance White or Off-White Crystalline Powder
NMR Consistent with Structure
Solubility Meets the Requirements
Max. Single Impurity ≤0.20%
Total Impurities ≤0.50%
Moisture (K.F) ≤1.0%
Residue of Ignition ≤0.20%
Heavy Metals ≤20ppm
Purity ≥99.0%
Test Standard Enterprise Standard
Usage API,  Atypical Antipsychotic Drug (AAPD)

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Lurasidone Hydrochloride (CAS 367514-88-3) with high quality, API.

Lurasidone Hydrochloride (CAS 367514-88-3) is an orally administered substance that belongs to the class of atypical antipsychotic drugs (AAPD), developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States. It received approval by the EMA in 2014 for schizophrenia. Lurasidone has also been launched in a number of countries outside the US and EU, including Canada, where it is approved for both indications. It is produced through a multi-step chemical process.


Product detail pictures:

Good User Reputation for Irinotecan - Lurasidone Hydrochloride CAS 367514-88-3 API High Purity  – Ruifu detail pictures


Related Product Guide:

With our leading technology as well as our spirit of innovation,mutual cooperation, benefits and development, we will build a prosperous future together with your esteemed company for Good User Reputation for Irinotecan - Lurasidone Hydrochloride CAS 367514-88-3 API High Purity – Ruifu , The product will supply to all over the world, such as: Stuttgart, Swiss, Vietnam, Our products are mainly exported to Southeast Asia, the Middle East, North America and Europe. Our quality is surely guaranteed. If you are interested in any of our products or would like to discuss a custom order, please feel free to contact us. We are looking forward to forming successful business relationships with new clients around the world in the near future.
  • Staff is skilled, well-equipped, process is specification, products meet the requirements and delivery is guaranteed, a best partner!
    5 Stars By Elizabeth from Lithuania - 2018.05.13 17:00
    This company conforms to the market requirement and joins in the market competition by its high quality product, this is an enterprise that have Chinese spirit.
    5 Stars By Laura from Iran - 2018.02.08 16:45
    Write your message here and send it to us